LACONIA — At the intersection of Union and Gilford Avenues, for many years, medical patients filled their prescriptions at the Rite Aid pharma…
FRIDAY, Aug. 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system.
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals are ahead.
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health risks; buy from trusted sources.
Scientists have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s disease.
The findings show music therapy could be used as an alternative to drugs.
WEDNESDAY, July 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications, including certain formulations of amphetamine and methylphenidate, to warn about the medication's risk for weight loss and other adverse reactions in patients younger than 6 years of age.